NL-OMON38715
Completed
Not Applicable
A pilot study to investigate cardiac adverse effects of ropivacaine using local infiltration anaesthesia (LIA) technique during total hip arthroplasty (THA). - CaRoH
Reinier de Graaf Groep0 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Total Hip Artroplasty (THA) / total hip replacement
- Sponsor
- Reinier de Graaf Groep
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients 18 years and older and scheduled for THA in Reinier de Graaf hospital.
Exclusion Criteria
- •Allergy for ropivacaine.
- •Moderate or severe cardiac disease, bronchial asthma (severe valave insuffiency, angina pectoris 2/4 or more, congestive heart failure, rhythmic disorder).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pilot study to determine the effect on cardiac output of standard pulmonary rehabilitation exercises in patients with pulmonary hypertensiopulmonary hypertensionRespiratory - Other respiratory disorders / diseasesACTRN12618000733279Department of Respiratory and Sleep Medicine, Princess Alexander Hospital20
Recruiting
Not Applicable
Pilot study to investigate cardiovascular interoception in patients with anorexia nervosa compared to healthy subjects using a new paradigm for heartbeat detectioF50.0Anorexia nervosaDRKS00034134FSU Jena, Klinische Psychologie60
Completed
Phase 2
Multiple Dose Study in Heart Failure of BAY 1067197Heart FailureNCT02040233Bayer31
Completed
Not Applicable
Myocardial preconditioning in coronary artery bypass surgeryISRCTN01775128niversity College London (UCL) (UK)500
Active, not recruiting
Not Applicable
A pilot study to investigate the safety and efficacy of a combined treatment with Gemcitabine and Sulfasalazine in pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinoma, non resectableMedDRA version: 9.1Level: LLTClassification code 10033600Term: Pancreatic adenocarcinoma non-resectableEUCTR2006-005104-14-DEniversitätsklinikum Schleswig-Holstein20